Beech Allergy Shots (SCIT)
American beech (Fagus grandifolia) is the underrated Fagales allergen β 66% Bet v 1 sequence identity at Fag s 1 makes it the lowest-identity Fagales sibling, but 2023 T-cell data from Polak et al. show Fag s 1 can sensitize independently of birch in some patients, challenging the assumption that beech allergy is always just birch cross-reactivity.
About Curexβs SCIT program
Curexβs at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- β’ Pollens β tree, grass, weed & ragweed
- β’ Pet dander β cat & dog
- β’ Dust mites
- β’ Molds β Alternaria & mold mix
Beechis covered here for general education and may not be part of Curexβs current treatment set. Join the waitlist and our care team will help confirm your options.
Beech Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to beech β rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of beech allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7β10 years.
There are two evidence-based forms of beech immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course β the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of beech extract in a clinic, escalating over 3β6 months until a maintenance dose is reached. Continued monthly for 3β5 years. Longest clinical track record for beech allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50β100+ in-person clinic visits across the full course
- Or at home with no clinic visitsβ Curexβs Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing beech extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home β no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription beech immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots β protocol, efficacy data, side effects, and cost. If youβd rather skip the clinic and treat beech allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Beech?
The biology, taxonomy, and clinical fingerprint of Beech β the foundation of how SCIT targets it.
American beech (Fagus grandifolia) is native to the eastern US, especially the Northeast and Appalachians. Its Fag s 1 allergen carries the lowest Bet v 1 sequence identity of any Fagales tree in common SCIT use β 66% β yet recent T-cell data confirm it can sensitize patients independently of birch.
- Scientific name
- Fagus grandifolia Ehrh. / F. sylvatica L.
- Family
- FagaceaeBeech family
- Type
- Deciduous tree pollen
- Native to
- F. grandifolia (American beech) β eastern US, especially Northeast and Appalachians; F. sylvatica (European beech) β ornamental in US
- Allergen proteins
- Fag s 1 (major) β PR-10, ~17 kDa, 66% sequence identity with Bet v 1 (WHO/IUIS; PDB 6ALK structure)NOTE: Fag s 1 is formally named at WHO/IUIS; no other Fagus allergens are currently named at IUIS for F. grandifolia
- Particle size
- ~30β40 ΞΌm
- Avoidance difficulty
- Nearly impossible
How Beech Allergy Presents
Symptoms by body system β useful for distinguishing Beech sensitivity from overlapping allergies and infections.
Respiratory
- Sneezing and rhinorrhea during AprilβMay beech pollen season in the Northeast and Appalachians
- Nasal congestion overlapping with oak and birch seasons β making attribution difficult without skin testing
- Itchy, swollen nasal passages on high-pollen days in beech-rich Appalachian and northern hardwood forests
- Potential asthma exacerbations in sensitized patients during peak season
- Post-nasal drip and cough during the 4β6 week beech pollen window
Ocular
- Bilateral eye itching and watering during the AprilβMay beech season
- Conjunctival redness on high-pollen days in forested areas
- Morning eyelid puffiness from overnight pollen accumulation
- Periorbital swelling that may be worse on windy days in beech-canopy environments
Dermal
- Oral allergy syndrome (OAS) to raw apple, hazelnut kernel, peach, cherry, carrot, and celery via Fag s 1 / Bet v 1 PR-10 cross-reactivity β same food spectrum as birch OAS; heat-labile
- Atopic dermatitis flares coinciding with Fagales spring pollen season in susceptible patients
- Contact urticaria in highly sensitized individuals after direct pollen exposure
Systemic
- Fatigue from prolonged spring pollen season when beech overlaps with birch and oak in May
- Sleep disruption from nasal congestion during peak weeks
- Impaired outdoor activity tolerance in Northeast and Appalachian forests during spring
- Diagnostic confusion β beech, birch, and oak all peak in the same spring window in the Northeast
Most allergists treat beech as a birch cross-reactor, but the Polak 2023 T-cell data showed Fag s 1 can sensitize independently β which is why I now check Fag s 1 IgE in Northeast patients who don't fully respond to a birch-only SCIT mix. Beech is rarely the anchor, but it can be the missing piece.
When & Where Beech Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: late April through May in the Northeast and Appalachians β overlapping with the tail end of birch and oak seasonsΒ· ~4β6 weeks; often masked by co-occurring birch and oak pollen in the same spring window
US Exposure Map
8 high-intensity statesExposure intensity by state (text version)
- ME:
- High
- VT:
- High
- NH:
- High
- WA:
- None
- MT:
- None
- ND:
- None
- MN:
- Low
- WI:
- Moderate
- MI:
- Moderate
- NY:
- High
- MA:
- High
- OR:
- None
- ID:
- None
- WY:
- None
- SD:
- None
- IA:
- Low
- IL:
- Low
- IN:
- Low
- OH:
- Moderate
- PA:
- High
- NJ:
- Moderate
- CT:
- Moderate
- RI:
- Moderate
- CA:
- None
- NV:
- None
- UT:
- None
- CO:
- None
- NE:
- None
- MO:
- Low
- KY:
- Moderate
- WV:
- High
- VA:
- High
- MD:
- Moderate
- DE:
- None
- AZ:
- None
- NM:
- None
- KS:
- None
- AR:
- Low
- TN:
- Moderate
- NC:
- Moderate
- SC:
- Low
- OK:
- None
- LA:
- None
- MS:
- Low
- AL:
- Low
- GA:
- Low
- TX:
- None
- FL:
- None
- AK:
- None
- HI:
- None
What Beech Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Beech Fag s 1 shares 66% sequence identity with birch Bet v 1 β the lowest in the common Fagales group β yet Polak et al. (Allergy 2023) showed that T cells specific to Fag s 1 peptides can sensitize independently of birch, establishing beech as more than a simple birch cross-reactor in some patients.
Fag s 1 β 66% Bet v 1 identity; full PR-10 cross-reactivity; Polak 2023 T-cell data confirm independent sensitization possible
Same PR-10 cross-reactivity; birch SCIT cross-protects against beech season via Itulazax TT-04
Mal d 1 PR-10 OAS β same heat-labile spectrum as birch; see white-birch for full food table
Fagales PR-10 sibling; Aln g 1 high T-cell cross-reactivity with Fag s 1 (Polak 2023)
Cor a 1 β Fagales PR-10 cousin; co-sensitization common in Northeast patients
Cor a 1.04 β PR-10 OAS; heat-labile
Beech Fag s 1 PR-10 Oral Allergy Syndrome
Fag s 1 shares the same PR-10 structural fold as birch Bet v 1, meaning beech-sensitized patients may experience OAS to the same raw foods as birch-allergic patients β apple, hazelnut kernel, peach, cherry, carrot, celery. These reactions are heat-labile and typically resolve when the food is cooked. Because beech and birch season overlap in the Northeast, attributing OAS specifically to beech sensitization (rather than co-existing birch) requires component-resolved testing. See the white birch page for the complete PR-10 OAS food table.
Is SCIT Right for Your Beech Allergy?
Answer five questions to assess whether beech-specific testing and SCIT add-on is appropriate for your Northeast or Appalachian spring allergy profile.
How severe are your AprilβMay spring allergy symptoms in the Northeast or Appalachian region?
The Beech SCIT Protocol
Beech SCIT uses non-standardized Fagus extract, typically added to a birch-anchored Fagales mix rather than prescribed as a standalone extract. Beech is rarely the primary SCIT target β it is most clinically relevant as an add-on for Northeast/Appalachian patients with documented Fag s 1 IgE who show incomplete response to birch monotherapy.
Build-up follows the same standard Fagales SCIT ladder as birch and oak. When beech is added to an existing birch-anchored mix, the total extract is reconstituted accordingly and build-up may restart from a lower concentration. Mandatory 30-minute post-injection observation at all visits.
Ongoing maintenance including beech extract in a Fagales mix sustains Fag s 1 tolerance alongside the broader birch-homologous PR-10 response. The Itulazax TT-04 birch-homologous indication covers beech as part of the family-level immunotherapy target.
Lasting benefit of 7β12+ years is expected with full course completion in the context of a complete Fagales mix that includes beech.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Beech SCIT
No beech-specific SCIT RCT has been conducted, and no US sensitization prevalence data exist for Fagus grandifolia. All clinical use extrapolates from the birch-homologous Fagales family evidence, with Polak 2023 providing the most specific beech-relevant mechanistic data.
- Fagales season cross-protection (birch-homologous family including beech)65%Itulazax TT-04 Phase 3, EMA 2019, N=634 adults (birch-homologous indication covers beech)
- T-cell cross-reactivity across Fagales including beech (Fag s 1)78%Polak D et al., Allergy 2023 (T-cell cross-reactivity across birch, alder, hazel, oak, beech PR-10 group)
No beech-specific SCIT RCT exists and no US prevalence data have been published. The Polak 2023 T-cell data are the most specific available evidence for beech in the context of Fagales immunotherapy, confirming both high T-cell cross-reactivity with the birch-homologous group and the possibility of independent Fag s 1 sensitization. Beech SCIT is best understood as a low-priority Fagales add-on for a minority of Northeast/Appalachian patients with confirmed Fag s 1 IgE who respond incompletely to birch-only immunotherapy.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Beech SCIT Side Effects
Beech SCIT side effects, when beech extract is added to a Fagales mix, follow the standard inhalant SCIT profile. No beech-specific safety data differ from other Betulaceae/Fagaceae extracts.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Expected during build-up; resolves within 24 hours | Rate 30β50% | Mild |
Injection-site itching Ice and pre-treatment antihistamine recommended | Rate 20β40% | Mild |
Large local reaction (>25 mm) Higher during active Fagales pollen season; a summer start is preferred | Rate 5β10% | Moderate |
Persistent redness and warmth Resolves within 24 hours in most cases | Rate 10β20% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis/conjunctivitis flare Sneezing or eye watering within minutes to 1 hour; antihistamine responsive | Rate 0.5β1% | Mild |
Urticaria Generalized hives; managed with antihistamines Β± epinephrine | Rate 0.1β0.5% | Moderate |
Bronchospasm Asthmatic patients at elevated risk; spirometry before SCIT is recommended | Rate 0.1β0.3% | Moderate |
Anaphylaxis Rare at properly titrated doses; a prescribed epinephrine auto-injector is confirmed on hand and trained Curex clinical staff supervises the first injection from each new vial or concentration live in the Virtual Shot Room, with a 30-minute self-observation after each dose. | Rate <0.01% | Severe |
Beech extract is typically not used as a standalone SCIT component β it is added to a Fagales mix. The 30-minute post-injection observation period applies to all SCIT visits. Patients with active PR-10 OAS to raw apple or hazelnut should disclose this before each visit.
SCIT vs Alternatives for Beech
Patients with confirmed Fag s 1 sensitization have four options: adding beech to a Fagales SCIT mix β now self-administered as a weekly at-home shot with Curex β sublingual drops, avoidance (impractical in beech-rich forests), and seasonal medications.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Moderate β family-level evidence via Itulazax TT-04; beech-specific evidence limited to Polak 2023 T-cell data | Moderate β no FDA-approved beech SLIT tablet; off-label drops available | Low β American beech is widespread in Northeast and Appalachian forests | Moderate β antihistamines + nasal corticosteroids for mild-to-moderate symptoms |
| 5-yr cost | $3,500β$15,000 over 5 years | Varies by provider; sublingual drops are a general allergy modality, not Curex's product | Low β HEPA, pollen masks when in forested areas | $500β$2,000 over 5 years |
| Duration | 3β5 year course | 3β5 year course | Indefinite β no tolerance change | Indefinite β seasonal use |
| Convenience | At-home weekly self-injection with Curex; summer start preferred; the first injection from each new vial or concentration supervised live in the Virtual Shot Room | Daily at-home β no clinic required | Moderate inconvenience AprilβMay in forested areas | High convenience |
| Safety | Excellent β your beech serum is USP <797> sterile-compounded, trained Curex clinical staff supervises the first injection from each new vial or concentration in the Virtual Shot Room, a prescribed epinephrine auto-injector is on hand, and a 30-minute self-observation follows | Favorable β no systemic anaphylaxis in EU SLIT trials | Safe | Generally safe |
| Lasting effect | 7β12+ years after completion | Emerging β less durability data vs SCIT | None β symptoms return each April | None β must take every season |
SCITBest
SLIT
Avoidance
Medications
For patients with confirmed Fag s 1 sensitization, adding beech to a Fagales SCIT mix may improve the completeness of Fagales-season coverage β particularly for those with partial response to birch-only immunotherapy β and with Curex, eligible patients self-administer that mix at home with pricing confirmed in a current program quote, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room and a prescribed epinephrine auto-injector confirmed on hand.
What Beech SCIT Actually Costs
Beech is typically included as part of a Fagales multi-allergen SCIT mix and billed accordingly under standard allergy immunotherapy codes. Most major US insurers cover Fagales SCIT when ordered by a board-certified allergist with documented sensitization. Pre-authorization covering the full extract composition is recommended. Curex at-home IgE testing identifies specific beech sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your beech allergy. Get a plan.
Take Curexβs 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you β shots or drops.
Free quiz Β· Board-certified allergists Β· 50,000+ patients treated Β· HSA/FSA eligible
Beech SCIT β Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Beech allergy is clinically present but under-recognized β partly because beech pollen season overlaps entirely with birch and oak in the Northeast (AprilβMay), making it easy to attribute all spring symptoms to the better-known allergens. No US-wide sensitization prevalence study has been published for Fagus grandifolia specifically. The IUIS has formally named Fag s 1, confirming it as a documented IgE-binding allergen, but beech rarely appears as a standalone clinical diagnosis. The Polak 2023 T-cell study is the most recent evidence that Fag s 1 can drive independent sensitization β raising the profile of beech as a potentially underdiagnosed component of Northeast spring pollen allergy.
It's a legitimate diagnostic consideration. The Polak 2023 T-cell study (Allergy 2023) confirmed that T cells reactive to Fag s 1 peptides can be independently sensitized β meaning some patients have genuine beech-specific T-cell responses that are not fully cross-desensitized by a birch-monotherapy SCIT approach. If you live in the Northeast or Appalachian region, spend time in beech-rich forests, and show partial but incomplete response to a birch-anchored Fagales SCIT mix, asking your allergist about Fag s 1 component testing is a reasonable next step. Adding beech extract to the mix may improve coverage for the small subset of patients with true Fag s 1 primary sensitization.
Yes, through the same PR-10 OAS mechanism. Fag s 1 shares 66% sequence identity with birch Bet v 1, meaning beech-sensitized patients may experience the same oral allergy syndrome to raw apple, hazelnut kernel, peach, cherry, carrot, and celery as birch-allergic patients. These reactions are heat-labile β cooking or canning the food typically resolves the OAS completely. Because beech and birch co-sensitization is common in the Northeast, attributing OAS specifically to beech rather than co-existing birch requires component testing for both Fag s 1 and Bet v 1. In most cases, the birch Bet v 1 protein is the stronger driver of PR-10 OAS even in patients with documented beech sensitization.
No. Beech pollen (Fag s 1) is an inhalant allergen that enters via the respiratory tract and drives rhinitis, conjunctivitis, and asthma during the AprilβMay pollen season. Beechnuts (the seeds of Fagus species) contain their own storage proteins β but unlike walnut and pecan kernels, beechnut kernel allergens have not been formally characterized at WHO/IUIS. In practice, beechnut food allergy is extremely rare in clinical practice in the US. If you have a beechnut reaction, a board-certified allergist should evaluate whether it reflects genuine beechnut sensitization versus OAS cross-reactivity from Fag s 1 pollen via the PR-10 pathway.
The Polak 2023 study published in Allergy made two important contributions for beech. First, it confirmed very high T-cell cross-reactivity across the entire Fagales PR-10 group β birch, alder, hazel, oak, and beech β providing a mechanistic explanation for why the Itulazax TT-04 birch-homologous SCIT program reduces symptoms across all five trees despite using only Bet v 1 as the immunotherapy allergen. Second, and more specifically for beech, it showed that T cells reactive to Fag s 1 peptides can exist in some patients independently of Bet v 1-driven sensitization. This means that for a minority of patients, beech is not merely a birch cross-reactor but a genuine primary sensitizer β which may explain some cases of incomplete response to birch-monotherapy SCIT in the Northeast and Appalachian region.
The main clinical signal is incomplete response to a birch-anchored Fagales SCIT mix combined with significant spring symptoms in an area with high beech pollen exposure. If you live or work in Northeast or Appalachian forests and continue to have moderate-to-severe AprilβMay rhinitis and conjunctivitis after 12β18 months of birch-anchored SCIT at maintenance dose, asking your allergist to run a Fag s 1 component blood test is reasonable. If Fag s 1 IgE is elevated, adding beech extract to the mix may improve coverage. However, beech is a low-tier add-on β most allergists treat the Fagales family with a birch-anchored mix and find it adequate for the vast majority of patients.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs β including the parts that are not flattering.